---
$id: https://graph.org.ai/products/commodity/51111862
$type: Product
source: UNSPSC
code: "51111862"
title: "Nilotinib"
class: "51111800"
classTitle: "Hormones and antihormones"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Nilotinib

**UNSPSC Code**: 51111862
**Class**: [Hormones and antihormones](Hormones and antihormones.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a tyrosine kinase inhibitor with the molecular formula C28H22F3N7O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier F41401512X. European Medicines Agency schedules nilotinib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB25225. The term NILOTINIB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 20, no. 3, 2006, list 56). Most nations schedule nilotinib under HS 29335990 and SITC 51576. As of Q4 2014, NILOTINIB remains the US FDA Preferred Term for this commodity. Nilotinib bears US NLM identifiers UMLS ID C1721377 and NCI Concept Code C48375. SMILES: CL.FC(F)(F)C1CC(N2CC(NC2)C)CC(NC(=O)C2CC(NC3NC(C4CCCNC4)CCN3)C(CC2)C)C1.O.

